Proteomic analysis of vitreal exosomes in patients with proliferative diabetic retinopathy

• Published in: Eye (London) 2023-07, Vol.37 (10), p.2061-2068
• Main Authors: Wang, Jiawei, Wang, Zhenzhen, Zhang, Ying, Li, Jianqiao
• Format: Article
• Language: English
• Subjects: 692/53/2423; 692/699/3161/3175; 82/47; 82/58; Apolipoprotein B; Apolipoproteins; Biomarkers; Biomarkers - metabolism; Diabetes; Diabetes Mellitus; Diabetic retinopathy; Diabetic Retinopathy - metabolism; Exosomes; Exosomes - metabolism; Genomes; Gluconeogenesis; Glycolysis; Humans; Hypoxia-inducible factor 1; Hypoxia-inducible factors; L-Lactate dehydrogenase; Laboratory Medicine; Mannose; Medicine; Medicine & Public Health; Metabolic pathways; Metabolism; NAD; Ophthalmology; Pharmaceutical Sciences/Technology; Proteins; Proteomics; Proteomics - methods; Retinopathy; Signal transduction; Surgery; Surgical Oncology; Therapeutic targets; Ultracentrifugation; Vitreous Body - metabolism
• ISSN: 0950-222X; 1476-5454; 1476-5454
• DOI: 10.1038/s41433-022-02286-x

Purpose To determine the proteomic profiles of exosomes derived from vitreous humour (VH) obtained from proliferative diabetic retinopathy (PDR) patients and non-diabetic controls with idiopathic macular hole/epiretinal membrane. Methods Vitreal exosomes were isolated using differential ultracentrifugation, followed by characterisation performed using different techniques. A label-free proteomic analysis was conducted to determine the protein profiles of the exosomes. A parallel reaction monitoring (PRM) analysis was performed to verify the identified proteins and associated functional annotations were derived by gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Receiver operating characteristic (ROC) analysis was utilised to evaluate the diagnostic value of target proteins in distinguishing PDR from controls. Results Exosomes were successfully isolated from VH, and were well characterised by various techniques. The results of proteomic analysis showed that a total of 758 proteins were identified and 10 proteins were screened as differentially expressed proteins, significantly changed in the PDR group containing 4 elevated proteins and 6 reduced proteins. GO analysis indicated that these differential proteins were mainly involved in many metabolic pathways, including nicotinamide adenine dinucleotide metabolism, adenosine diphosphate metabolic process and glycolytic process. The KEGG analysis enriched the top five pathways including glycolysis/gluconeogenesis, fructose and mannose metabolism, biosynthesis of amino acids, hypoxia-inducible factor 1 signalling pathway and carbon metabolism. The differential proteins, namely, lactate dehydrogenase A, ficolin 3, apolipoprotein B and apolipoprotein M, were further verified by PRM and showed a consistent trend with label-free proteomic analysis. The ROC analysis identified these proteins as promising biomarkers for PDR diagnosis. Conclusions Vitreal exosomes from patients with PDR contained few proteins unique to PDR; thus, exosomal proteins have great potential as disease biomarkers and therapeutic targets for PDR.